Related Experiment Video
Updated: Jul 2, 2026
Experimental Demyelination and Remyelination of Murine Spinal Cord by Focal Injection of Lysolecithin
Published on: March 26, 2015
iRhom1 rescues cognitive dysfunction in multiple sclerosis via preventing myelin injury
Haolu Sun1, Hui Yang1, Yiwang Wu1
1School of Basic Medical Sciences, Anhui Medical University, Hefei, China.
Abstract:
Multiple sclerosis (MS) is characterized by myelin sheath injury. A disintegrin and metalloprotease-17 (ADAM17), a disintegrin and metalloproteinase, is essential in regulating oligodendrocyte (OL) regeneration and remyelination under demyelinating conditions. iRhom1, a highly conserved inactive protease that belongs to the rhomboid family, is one of key regulators for ADAM17 maturation. However, it is unknown whether iRhom1 also plays a role in central neuron system myelination under demyelinating conditions like MS. In this study, we investigated the function of iRhom1/ADAM17 in cognitive capability in MS by establishing the mice with iRhom1 overexpression in the hippocampus.
Insights
This study explores iRhom1
Area of Science:
- Neuroscience
- Cell Biology
Background:
- Multiple sclerosis (MS) involves myelin sheath damage in the central nervous system.
- ADAM17 (a disintegrin and metalloproteinase-17) is crucial for oligodendrocyte regeneration and remyelination.
- iRhom1 regulates ADAM17 maturation but its role in MS-related myelination is unknown.
Purpose of the Study:
- To investigate the function of the iRhom1/ADAM17 pathway in cognitive function within the context of MS.
- To determine the impact of iRhom1 in central nervous system myelination during demyelinating conditions.
Main Methods:
- Established a mouse model with hippocampus-specific overexpression of iRhom1.
- Evaluated the role of iRhom1/ADAM17 in cognitive deficits associated with MS.
- Assessed oligodendrocyte regeneration and remyelination processes.
Main Results:
- Overexpression of iRhom1 in the hippocampus influenced cognitive capabilities in the MS model.
- The iRhom1/ADAM17 pathway was implicated in the regulation of myelination and cognitive function.
- Findings suggest a novel role for iRhom1 in central nervous system repair mechanisms.
Conclusions:
- iRhom1 plays a significant role in regulating cognitive function during demyelinating conditions like MS.
- Targeting the iRhom1/ADAM17 pathway may offer therapeutic strategies for cognitive impairment in MS.
- Further research is warranted to fully elucidate the mechanisms involved.
More Related Videos
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
08:40Positron Emission Tomography Imaging for In Vivo Measuring of Myelin Content in the Lysolecithin Rat Model of Multiple Sclerosis
Published on: February 28, 2021
